OTCMKTS:IGXT

IntelGenx Technologies Short Interest Ratio and Short Volume

$0.35
0.00 (-0.54 %)
(As of 07/23/2021 03:59 PM ET)
Add
Compare
Today's Range
$0.34
$0.38
50-Day Range
$0.34
$0.62
52-Week Range
$0.12
$0.69
Volume101,095 shs
Average Volume311,084 shs
Market Capitalization$39.20 million
P/E RatioN/A
Dividend YieldN/A
Beta2.71

IntelGenx Technologies (OTCMKTS:IGXT) Short Interest Data

Current Short Volume10,600 shares
Previous Short Volume102,700 shares
Change Vs. Previous Month-89.68%
Dollar Volume Sold Short$5,406.00
Short Interest Ratio / Days to Cover0.0
Last Record DateJune, 30 2021
Outstanding Shares111,994,000 shares
Percentage of Shares Shorted0.01%
Today's Trading Volume101,095 shares
Average Trading Volume311,084 shares
Today's Volume Vs. Average-67.50%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling IntelGenx Technologies ?

Sign up to receive the latest short interest report for IntelGenx Technologies and its competitors with MarketBeat's FREE newsletter.

IntelGenx Technologies (OTCMKTS:IGXT) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202110,600 shares $5,406.00 -89.7%N/A0 $0.51
6/15/2021102,700 shares $63,674.00 +256.6%N/A0.2 $0.62
5/28/202128,900 shares $14,737.56 -35.5%N/A0.1 $0.51
5/14/202144,800 shares $24,864.00 +513.7%N/A0.1 $0.56
4/30/20217,300 shares $4,618.35 -45.5%N/A0 $0.63
4/15/202113,400 shares $6,535.18 -88.7%N/A0 $0.49
3/31/2021118,200 shares $52,362.60 +82.1%N/A0.2 $0.44
3/15/202164,900 shares $20,884.82 +136.0%N/A0.2 $0.32
2/26/202127,500 shares $9,350.00 -15.6%N/A0 $0.34
2/12/202132,600 shares $10,269.00 +5,333.3%N/A0 $0.32
1/29/2021600 shares $149.24 -99.2%N/A0 $0.25
1/15/202138,700 shares $10,226.09 -1.8%N/A0.1 $0.26
12/31/202011,700 shares $2,585.70 -69.8%N/A0 $0.22
12/15/202038,700 shares $12,384.00 -1.8%N/A0.1 $0.32
11/30/202039,400 shares $10,530.83 +118.9%N/A0.1 $0.27
11/15/202018,000 shares $4,042.80 -38.8%N/A0.1 $0.22
10/30/202029,400 shares $4,151.28 +40.0%N/A0.2 $0.14
10/15/202021,000 shares $3,076.50 -16.7%N/A0.1 $0.15
9/30/202025,200 shares $3,528.00 -54.3%N/A0.1 $0.14
9/15/202055,100 shares $8,920.69 -14.7%N/A0.1 $0.16
8/31/202064,600 shares $10,465.20 -38.5%N/A0.2 $0.16
8/14/2020105,100 shares $16,290.50 +37.2%N/A0.3 $0.16
7/31/202076,600 shares $15,932.80 +15.5%N/A0.2 $0.21
7/15/202066,300 shares $14,718.60 -7.0%N/A0.2 $0.22
6/30/202071,300 shares $14,616.50 -48.3%N/A0.2 $0.21

IntelGenx Technologies (OTCMKTS:IGXT) Short Interest FAQ

speech bubbles
speech bubbles











What is IntelGenx Technologies' current short interest?

Short interest is the volume of IntelGenx Technologies shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 10,600 shares of IGXT short. Learn More on IntelGenx Technologies' current short interest.

Is IntelGenx Technologies' short interest increasing or decreasing?

IntelGenx Technologies saw a decrease in short interest in June. As of June 30th, there was short interest totaling 10,600 shares, a decrease of 89.7% from the previous total of 102,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does IntelGenx Technologies' short interest compare to its competitors?

0.00% of IntelGenx Technologies' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to IntelGenx Technologies: ContraFect Co. (9.33%), BioLineRx Ltd. (0.00%), Galectin Therapeutics Inc. (6.54%), Lantern Pharma Inc. (4.30%), Larimar Therapeutics, Inc. (2.38%), Calithera Biosciences, Inc. (3.23%), Adamis Pharmaceuticals Co. (0.00%), Savara Inc (2.34%), AcelRx Pharmaceuticals, Inc. (9.28%), and OptiNose, Inc. (13.29%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($8.32 billion), AstraZeneca PLC ($8.20 billion), Square, Inc. ($7.79 billion), Analog Devices, Inc. ($7.16 billion), S&P Global Inc. ($7.07 billion), Aon plc ($6.17 billion), Charter Communications, Inc. ($5.38 billion), Wayfair Inc. ($4.80 billion), AMC Entertainment Holdings, Inc. ($4.28 billion), and Snowflake Inc. ($3.19 billion). View all of the most shorted stocks.

What does it mean to sell short IntelGenx Technologies stock?

Short selling IGXT is an investing strategy that aims to generate trading profit from IntelGenx Technologies as its price is falling. IntelGenx Technologies' stock is trading down $0.00 today. To short IntelGenx Technologies stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that IntelGenx Technologies will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against IntelGenx Technologies?

A short squeeze for IntelGenx Technologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IGXT, which in turn drives the price of the stock up even further.

How often is IntelGenx Technologies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IGXT, twice per month. The most recent reporting period available is June, 30 2021.



This page was last updated on 7/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.